Prestwick3_000314

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers, 18 USDMF, 14 CEP/COS, 4 JDMF, 6 EU WC, 11 KDMF, 13 NDC API, 16 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

670 Dossiers, 90 FDA Orange Book, 374 Europe, 46 Canada, 35 Australia, 41 South Africa, 84 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 18 Roquette, 13 Microlex e.U, 11 Sigachi Industries, 10 Corel Pharma Chem, 9 BASF, 9 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 6 Lonza Capsugel, 6 DFE Pharma, 6 Gangwal Chemicals, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 5 SPI Pharma, 3 Kima Chemical, 3 Ingredion Pharma Solutions, 3 Prachin Chemical, 3 Vasa Pharmachem, 2 Actylis, 2 The Dow Chemical Company, 1 Pharmatrans-Sanaq, 1 Pharm-RX Chemical, 1 Aeon Procare, 1 DKSH, 1 Bioplus Life Sciences, 1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 28 Direct Compression, 22 Controlled & Modified Release, 20 Disintegrants & Superdisintegrants, 19 Granulation, 18 Lubricants & Glidants, 13 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Taste Masking, 9 Film Formers & Plasticizers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Topical, 2 Parenteral, 2 Coloring Agents, 1 Solubilizers

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 303 Finished Drug Prices

MARKET PLACE

20 APIs, 12 DOSSIERS // FDF

PATENTS

29 US Patents, 10 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 3 JP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

28 News

28 News

Information, Expiry & Status of Health Canada Patents covering Prestwick3_000314.

Prestwick3_000314

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers

18 USDMF

14 CEP/COS

4 JDMF

6 EU WC

11 KDMF

13 NDC API

16 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

670 Dossiers

90 FDA Orange Book

374 Europe

46 Canada

35 Australia

41 South Africa

84 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 10MG;25MG

TABLET;ORAL - 5MG;12.5MG

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

18 Roquette

13 Microlex e.U

11 Sigachi Industries

10 Corel Pharma Chem

9 BASF

9 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

6 Lonza Capsugel

6 DFE Pharma

6 Gangwal Chemicals

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

5 SPI Pharma

3 Kima Chemical

3 Ingredion Pharma Solutions

3 Prachin Chemical

3 Vasa Pharmachem

2 Actylis

2 The Dow Chemical Company

1 Pharmatrans-Sanaq

1 Pharm-RX Chemical

1 Aeon Procare

1 DKSH

1 Bioplus Life Sciences

1 Jai Radhe Sales

1 Nanjing Well Pharmaceutical

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders

45 Coating Systems & Additives

28 Direct Compression

22 Controlled & Modified Release

20 Disintegrants & Superdisintegrants

19 Granulation

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons